Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IGF2BP2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Gene profile: IGF2BP2 - Insulin-like Growth Factor 2 mRNA-Binding Protein 2 involved in RNA localization, translation regulation, stress granule dynamics, synaptic function, and neurodegeneration
| Gene Symbol | IGF2BP2 |
| Full Name | Insulin-like Growth Factor 2 mRNA-Binding Protein 2 |
| Aliases | Gene profile: IGF2BP2 |
| Chromosome | 9q33.3 |
| Protein Family | IMP/VICKZ RNA-binding protein family |
| Function | is an RNA-binding protein belonging to the IMP (IGF2BP/CRD-BP/VICKZ) family. |
| Primary Expression | embryonic development and cancer |
| Molecular Weight | 66 kDa |
| Amino Acids | 630 aa |
| Exons | 16 |
| Pathways | Angiogenesis, Apoptosis, CRISPR-Cas, Epigenetic, Glycolysis |
| UniProt ID | [Q9NZH8](https://www.uniprot.org/uniprot/Q9NZH8) |
| Ensembl ID | ENSG00000113721 |
| GeneCards | IGF2BP2 |
| Human Protein Atlas | IGF2BP2 |
| Associated Diseases | Head And Neck Squamous Cell Carcinoma, Poor Prognosis |
| Interactions | PRKN, NOTCH1, TRPM2, BRD4, METTL3, CANCER |
| KG Connections | 87 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
IGF2BP2["<b>IGF2BP2</b>"]
Carcinoma{"Carcinoma"}
IGF2BP2 -->|"inhibits"| Carcinoma
Cancer{"Cancer"}
IGF2BP2 -->|"regulates"| Cancer
Tumor{"Tumor"}
IGF2BP2 -->|"activates"| Tumor
Ms{"Ms"}
IGF2BP2 -->|"activates"| Ms
IGF2BP2 -->|"activates"| Cancer
IGF2BP2 -->|"activates"| Carcinoma
IGF2BP2 -->|"therapeutic target"| Ms
LC3["LC3"]
IGF2BP2 -->|"regulates"| LC3
Epigenetic(["Epigenetic"])
IGF2BP2 -->|"inhibits"| Epigenetic
Autophagy(["Autophagy"])
IGF2BP2 -->|"inhibits"| Autophagy
PRKN["PRKN"]
IGF2BP2 -->|"activates"| PRKN
METTL3["METTL3"]
IGF2BP2 -->|"activates"| METTL3
CANCER["CANCER"]
CANCER -->|"regulates"| IGF2BP2
AUTOPHAGY["AUTOPHAGY"]
AUTOPHAGY -->|"inhibits"| IGF2BP2
CANCER -->|"activates"| IGF2BP2
APOPTOSIS["APOPTOSIS"]
APOPTOSIS -->|"activates"| IGF2BP2
HNRNPU["HNRNPU"]
HNRNPU -->|"interacts with"| IGF2BP2
MYC["MYC"]
MYC -->|"activates"| IGF2BP2
CSF1["CSF1"]
CSF1 -->|"activates"| IGF2BP2
CTCF["CTCF"]
CTCF -->|"activates"| IGF2BP2
EP300["EP300"]
EP300 -->|"interacts with"| IGF2BP2
style IGF2BP2 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Head And Neck Squamous Cell Carcinoma | associated_with | disease | 0.90 |
| Cell Proliferation | promotes | process | 0.90 |
| Cell Migration | promotes | process | 0.90 |
| Cell Invasion | promotes | process | 0.90 |
| Malignant Progression | promotes | process | 0.88 |
| Cell Proliferation | associated_with | process | 0.85 |
| Cell Migration | associated_with | process | 0.85 |
| Cell Invasion | associated_with | process | 0.85 |
| Poor Prognosis | associated_with | phenotype | 0.85 |
| Lymph Node Metastasis | contributes_to | phenotype | 0.80 |
| Carcinoma | inhibits | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Infection | activates | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| LC3 | regulates | gene | 0.60 |
| PRKN | activates | gene | 0.60 |
| NOTCH1 | activates | gene | 0.60 |
| TRPM2 | interacts_with | gene | 0.60 |
| CSF1R | therapeutic_target | gene | 0.60 |
| BRD4 | inhibits | gene | 0.60 |
| BRD4 | encodes | gene | 0.60 |
| Epigenetic | inhibits | pathway | 0.60 |
| Autophagy | inhibits | pathway | 0.60 |
| METTL3 | activates | gene | 0.60 |
| Apoptosis | activates | pathway | 0.60 |
| Epigenetic | activates | pathway | 0.60 |
| CANCER | activates | gene | 0.60 |
| Angiogenesis | activates | pathway | 0.60 |
| Notch | activates | pathway | 0.60 |
| ROS | activates | gene | 0.60 |
| ATP | activates | gene | 0.60 |
| Glycolysis | activates | pathway | 0.60 |
| ONCOGENES | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| HUB GENES | activates | gene | 0.60 |
| KLF7 | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| Raf | associated_with | protein | 0.60 |
| Igf | activates | protein | 0.60 |
| Ras | inhibits | protein | 0.60 |
| App | activates | protein | 0.60 |
| KLF7 | expressed_in | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| KLF7 | upregulates | gene | 0.95 |
| KLF7 | binds | gene | 0.93 |
| Super-Enhancer | associated_with | mechanism | 0.90 |
| Super-Enhancer | regulates | mechanism | 0.90 |
| KLF7 | correlates_with | gene | 0.88 |
| BRD4 | regulates | protein | 0.80 |
| MED1 | regulates | protein | 0.80 |
| HNRNPU | interacts_with | gene | 0.60 |
| MYC | activates | gene | 0.60 |
| CSF1 | activates | gene | 0.60 |
| CTCF | activates | gene | 0.60 |
| EP300 | interacts_with | gene | 0.60 |
| NOTCH1 | activates | gene | 0.60 |
| BRD4 | inhibits | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| AUTOPHAGY | inhibits | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| AND | contributes_to | gene | 0.60 |
| AND | interacts_with | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| KLF7 | activates | gene | 0.60 |
| ONCOGENES | activates | gene | 0.60 |
| HUB GENES | activates | gene | 0.60 |
| BRD4 | activates | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||